Sou Hu Cai Jing·2025-07-07 11:58Group 1 - The core point of the article highlights the performance and holdings of the Huatai-PineBridge Healthcare Flexible Allocation Mixed Fund A, which has shown significant returns over various time frames [1] - As of July 7, 2025, the fund's latest net value is 1.7320 yuan, reflecting a decrease of 2.26% [1] - The fund's performance over the past month is a return of 0.35%, ranking 1209 out of 2349 in its category; over the past six months, it has achieved a return of 49.18%, ranking 3 out of 2317; and since the beginning of the year, it has returned 43.85%, ranking 4 out of 2315 [1] Group 2 - The top ten stock holdings of the fund account for a total of 64.17%, with significant positions in companies such as Heng Rui Medicine (10.23%), Kelun Pharmaceutical (9.09%), and Bai Li Tianheng (8.94%) [1] - The fund was established on June 18, 2015, and as of March 31, 2025, it has a total scale of 4.408 billion yuan [1] - The fund manager, Zhang Wei, has extensive experience in the pharmaceutical sector, having held various positions in research and fund management since 2021 [2]